FDA Inspection 1341448 — Vitalant

Vitalant — FEI 3000207072

The FDA completed an inspection of Vitalant on Aug 13, 2026 in Goodyear, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 13, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Goodyear, AZ (United States)